Total neoadjuvant FOLFIRINOX in patients with resectable locally advanced gastric and gastroesophageal junction cancer: Updated survival results

被引：0
|
作者：
Sedova, M. [1 ]
Batov, M. [1 ]
Kolomeytseva, A. [1 ]
Khomyakov, V. [2 ]
Volchenko, N. [3 ]
Fedenko, A. A. [4 ]
Kaprin, A. [5 ]
机构：
[1] PA Hertsen Moscow Oncol Res Inst, Chemotherapy, Moscow, Russia
[2] PA Hertsen Moscow Oncol Res Inst, Thoracoabdominal Oncosurg, Moscow, Russia
[3] PA Herzen Moscow Res Oncol Inst Mosc, Oncomorphol, Moscow, Russia
[4] PA Hertsen Moscow Oncol Res Inst, Div Med Oncol, Moscow, Russia
[5] PA Herzen Moscow Res Oncol Inst, Minist Hlth Russian Federat, Natl Med Res Radiol Ctr NMRRC, Moscow, Russia
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.341
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
428P
引用
收藏
页码：S173 / S174
页数：2
相关论文
共 50 条
  • [31] Preliminary analysis of total neoadjuvant therapy for patients with locally advanced gastric (G) and gastroesophageal (GE) adenocarcinoma
    Roeland, Eric
    Kanter, Katie
    Wo, Jennifer Yon-Li
    Fish, Madeleine
    Nipp, Ryan David
    Van Seventer, Emily E.
    Parikh, Aparna Raj
    Allen, Jill N.
    Giantonio, Bruce J.
    Blaszkowsky, Lawrence Scott
    Keane, Florence
    Klempner, Samuel J.
    Ryan, David P.
    Auchincloss, Hugh G.
    Ott, Harald
    Lanuti, Michael
    Morse, Christopher
    Mullen, John Thomas
    Hong, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [32] Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma
    Fernandez, Eugenio
    Cacheux, Wulfran
    Frossard, Jean-Louis
    Koessler, Thibaud
    Abou, Magali
    Moniez, Michael
    Huber, Olivier
    Puppa, Giacomo
    Roth, Arnaud
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (05) : 552 - 556
  • [33] PREOPERATIVE TREATMENT WITH RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED GASTROESOPHAGEAL JUNCTION (GEJ) CANCER AND UNRESECTABLE LOCALLY ADVANCED GASTRIC CANCER
    Irena, Oblak
    Franc, Anderluh
    Vaneja, Velenik
    Jasna, But-Hadzic
    Ajra, Secerov-Ermenc
    Ana, Jeromen
    Ivica, Ratosa
    ANNALS OF ONCOLOGY, 2014, 25 : 45 - 45
  • [34] Modified FOLFIRINOX as neoadjuvant treatment in patients with borderline resectable and locally advanced pancreatic adenocarcinoma: A single-center study, updated with new data
    Ioannou, S.
    Zouki, D.
    Kardara, V.
    Exarchos, K.
    Arvanitou, E.
    Gkikas, K.
    Stavrou, N.
    Koronakis, G.
    Tourkantonis, I.
    Grivas, A.
    Kourakos, P.
    Gouveris, P.
    Kypreos, D.
    Korkolis, D.
    Tryfonopoulos, D.
    Demiri, S.
    Papaxoinis, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S98 - S98
  • [35] Impact of Pancreatic Resection on Survival in Locally Advanced Resectable Gastric Cancer
    Chang, Shih-Chun
    Tang, Chi-Ming
    Le, Puo-Hsien
    Kuo, Chia-Jung
    Chen, Tsung-Hsing
    Wang, Shang-Yu
    Chou, Wen-Chi
    Chen, Tse-Ching
    Yeh, Ta-Sen
    Hsu, Jun-Te
    CANCERS, 2021, 13 (06) : 1 - 18
  • [36] Perioperative epirubicin, oxaliplatin, and capectabine (EOX) in locally advanced resectable gastroesophageal junction and gastric adenocarcinoma.
    Kalachand, Roshni Deepa
    Mongan, Anne-Marie
    Doherty, Mark
    King, Sinead
    O'Farrell, Niamh
    Reynolds, John Vincent
    O'Byrne, Kenneth John
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] A pilot study of neoadjuvant FOLFIRINOX followed by chemoradiation for gastric and gastroesophageal cancer: Preliminary results.
    Wo, Jennifer Yon-Li
    Clark, Jeffrey William
    Allen, Jill N.
    Blaszkowsky, Lawrence Scott
    Keane, Florence
    Drapek, Lorraine C.
    Ryan, David P.
    Corcoran, Ryan Bruce
    Roeland, Eric
    Parikh, Aparna Raj
    Khandekar, Melin Janardan
    Heist, Rebecca Suk
    Morse, Christopher
    Yeap, Beow Y.
    Ulysse, Christine A.
    Christopher, Benjamin
    Lanuti, Michael
    Berger, David L.
    Mullen, John Thomas
    Hong, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
    Tian, Yuan
    Zhao, Qun
    Li, Yong
    Fan, Liqiao
    Zhang, Zhidong
    Zhao, Xuefeng
    Tan, Bibo
    Wang, Dong
    Yang, Peigang
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [39] Predictors of Resectability and Survival in Patients with Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment with FOLFIRINOX
    Hu, Hai-Jie
    Li, Fu-Yu
    ANNALS OF SURGERY, 2018, 268 (06) : E95 - E96
  • [40] Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX
    Michelakos, Theodoros
    Pergolini, Ilaria
    Fernandez-del Castillo, Carlos
    Honselmann, Kim C.
    Cai, Lei
    Deshpande, Vikram
    Wo, Jennifer Y.
    Ryan, David P.
    Allen, Jill N.
    Blaszkowsky, Lawrence S.
    Clark, Jeffrey W.
    Murphy, Janet E.
    Nipp, Ryan D.
    Parikh, Aparna
    Qadan, Motaz
    Warshaw, Andrew L.
    Hong, Theodore S.
    Lillemoe, Keith D.
    Ferrone, Cristina R.
    ANNALS OF SURGERY, 2019, 269 (04) : 733 - 740
12345